A phase I randomized, placebo-controlled, safety and efficacy study of a botulinum toxin type A topical gel for treatment of lateral canthal lines

被引：0
|
作者：
Garcia-Murray, Enrique [1 ]
Salcido-Calzadilla, Hector [1 ]
Waugh, Jacob [2 ]
机构：
[1] Hosp Santa Monica, Mexico City, DF, Mexico
[2] Revance Therapeut, Mountain View, CA USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2008年 / 58卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB32 / AB32
页数：1
相关论文
共 50 条
  • [21] Type A Botulinum Toxin in the treatment of bruxism clenching and facial pain: randomized blinded placebo-controlled study
    Tonello, S.
    Ferronato, G.
    Guarda-Nardini, L.
    XVII CONGRESSO NAZIONALE DELLA SOCIETA ITALIANA CHIRURGIA MAXILLO-FACCIALE (SICMF), 2011, : 501 - 502
  • [22] A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke
    Bakheit, AMO
    Pittock, S
    Moore, AP
    Wurker, M
    Otto, S
    Erbguth, F
    Coxon, L
    EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 (06) : 559 - 565
  • [23] Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia
    Lew, MF
    Adornato, BT
    Duane, DD
    Dykstra, DD
    Factor, SA
    Massey, JM
    Brin, MF
    Jankovic, J
    Rodnitzky, RL
    Singer, C
    Swenson, MR
    Tarsy, D
    Murray, JJ
    Koller, M
    Wallace, JD
    NEUROLOGY, 1997, 49 (03) : 701 - 707
  • [24] Efficacy and safety of neuronox for lateral canthal lines: a phase I/III, multicenter, randomized, double-blind, active-controlled study
    Lim, Youngkyoung
    Lee, Jong Hee
    Lee, Woo Shun
    Lee, Weon Ju
    Kim, Hei Sung
    Shin, Min Kyung
    Haw, Sik
    Huh, Chang-Hun
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2021, 32 (05) : 561 - 567
  • [25] Efficacy and safety of topical metformin gel in the treatment of acne vulgaris, a split face, placebo-controlled study
    Bedair, Nermeen
    Shamma, Rehab
    Abdo, Nesma Moustafa Kamel
    Elkomy, Mohammed
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB157 - AB157
  • [26] Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: A 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety
    Lowe, Nicholas J.
    Glaser, Dee Anna
    Eadie, Nina
    Daggett, Simon
    Kowalski, Jonathan W.
    Lai, Pan-Yu
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (04) : 604 - 611
  • [27] A double-blind, randomised, placebo-controlled study to evaluate efficacy and safety of botulinum toxin type b (myobloc/neurobloc) and botulinum toxin type A (dysport) for the treatment of spastic paraparesis
    Mancini, F
    Moglia, A
    Allena, M
    Sandrini, G
    Nappi, G
    Pacchetti, C
    MOVEMENT DISORDERS, 2004, 19 : S127 - S127
  • [28] Safety and Efficacy of EB-001, a Novel Type E Botulinum Toxin, in Subjects with Glabellar Frown Lines: Results of a Phase 2, Randomized, Placebo-Controlled, Ascending-Dose Study
    Yoelin, Steve G.
    Dhawan, Sunil S.
    Vitarella, Domenico
    Ahmad, Wajdie
    Hasan, Fauad
    Abushakra, Susan
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2018, 142 (06) : 847E - 855E
  • [29] Treatment of lateral epicondylitis with botulinum toxin. A randomized, double-blind, placebo-controlled trial
    Wong, SM
    Hui, ACF
    Tong, PY
    Poon, DWF
    Yu, E
    Wong, LKS
    ANNALS OF INTERNAL MEDICINE, 2005, 143 (11) : 793 - 797
  • [30] Efficacy and Safety of a Novel Formulation Liquid Botulinum Toxin, RelabotulinumtoxinA, When used for Combination Treatment of Glabellar and Lateral Canthal Lines
    Bertucci, Vince
    Schlessinger, Joel
    Joseph, John
    Shamban, Ava
    Lorenc, Z. Paul
    Weiss, Robert
    Baumann, Leslie
    Nestor, Mark S.
    Prather, Heidi B.
    Jones, Derek
    Donath, Alexander S.
    Kazin, Rebecca
    Lin, Xiaoming
    Coquis-Knezek, Sara
    TOXICON, 2024, 237 : 10 - 11
12345